⌘K
Loading ticker…
ABBVIE INC. · Healthcare · Pharmaceutical Products
As of 2026-06-26, ABBVIE INC. (ABBV) has a 3-month relative strength percentile of 71 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 56. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.6%, relative volume 8.38×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 71, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
ABBV is held by 24 ETFs as of Mar 2026. Top owner: VTI at 0.61% weight, $12.2B notional. Top 3 carry $26.9B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.61% | $12.2B |
| VOOVanguard S&P 500 ETF | 0.69% | $9.8B |
| IVViShares Core S&P 500 ETF | 0.69% | $4.9B |
| SPYState Street SPDR S&P 500 ETF | 0.69% | $4.5B |
| VTVVanguard Value ETF | 1.58% | $3.6B |
| XLVState Street Health Care Select Sector SPDR ETF | 7.25% | $2.8B |
| IWFiShares Russell 1000 Growth ETF | 1.39% | $1.6B |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.69% | $808M |
| JEPIJPMorgan Equity Premium Income ETF | 1.56% | $685M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.61% | $483M |
Showing 10 of 24 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABBV Jan avg: -0.35% median: 0.55% win: 50% σ: 6.53% n: 4 2022-04-12 → 2026-05-29 | ABBV Feb avg: 7.25% median: 5.62% win: 100% σ: 4.50% n: 4 2022-04-12 → 2026-05-29 | ABBV Mar avg: 0.24% median: 1.84% win: 75% σ: 4.61% n: 4 2022-04-12 → 2026-05-29 | ABBV Apr avg: -7.82% median: -6.88% win: 0% σ: 4.28% n: 5 2022-04-12 → 2026-05-29 | ABBV May avg: -2.16% median: -0.86% win: 40% σ: 4.57% n: 5 2022-04-12 → 2026-05-29 | ABBV Jun avg: 1.93% median: 1.83% win: 50% σ: 3.95% n: 4 2022-04-12 → 2026-05-29 (current) | ABBV Jul avg: 3.65% median: 4.94% win: 75% σ: 7.66% n: 4 2022-04-12 → 2026-05-29 | ABBV Aug avg: 2.30% median: 2.09% win: 50% σ: 7.85% n: 4 2022-04-12 → 2026-05-29 | ABBV Sep avg: 2.97% median: 1.01% win: 75% σ: 4.76% n: 4 2022-04-12 → 2026-05-29 | ABBV Oct avg: 0.30% median: -1.03% win: 50% σ: 7.18% n: 4 2022-04-12 → 2026-05-29 | ABBV Nov avg: 1.28% median: 2.64% win: 75% σ: 8.59% n: 4 2022-04-12 → 2026-05-29 | ABBV Dec avg: 1.65% median: 0.31% win: 75% σ: 5.02% n: 4 2022-04-12 → 2026-05-29 |